BHP Billiton Limited shares could be headed lower

BHP Billiton Limited (ASX:BHP) is partially responsible for coughing up fees to cover the environmental damage in Brazil.

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Global mining giants BHP Billiton Limited (ASX: BHP) and Vale have been specified by a Brazilian court as legally co-responsible for the Samarco mine disaster early in November this year.

The incident, which involved the catastrophic failure of one of Samarco's tailings dams, killed at least 13 people and made hundreds homeless. It also destroyed several villages, some of which were dozens of miles away from the dam, and caused what is estimated to be billions of dollars' worth of environmental damage.

While there has been much uncertainty regarding the incident itself and how it would impact the miners (BHP Billiton and Vale are joint 50/50 owners of Samarco), a Brazilian court has now provided some clarity. According to The Australian Financial Review, the court deemed BHP and Vale as "indirect polluters" which will likely see them be held responsible for any charges Samarco itself cannot cover.

The media report also noted that neither mining group had received formal notification of the decision and are thus yet to issue an official announcement to the market.

When combined with ongoing concerns regarding the sustainability of its 'progressive dividend' policy, together with crashing commodity prices, the incident at Samarco has had a dramatic impact on BHP Billiton's share price.

Since the incident on 6 November, BHP's shares have fallen more than 26% and recently hit their lowest price in more than 10 years. They've rebounded marginally since then, including a 1.7% rise today, and are now trading at $17.16 per share.

Motley Fool contributor Ryan Newman has no position in any stocks mentioned. Unless otherwise noted, the author does not have a position in any stocks mentioned by the author in the comments below. You can follow Ryan on Twitter @ASXvalueinvest. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »